Search

Search Results
Results 5291 - 5300 of 17261 for Active treatment
  • Imanib
    Drug - 21 Apr 2026
    Consumer Medicine Information (CMI) about Imanib intended for persons living in Australia.
  • Karvezide
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Avapro HCT
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.
  • Redesigning obesity trials for a chronic disease era
    White Paper - 17 Apr 2026
    Obesity trials are evolving toward chronic disease models with improved endpoints, longer study designs, and greater clinical relevance.
  • Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus
    News - 17 Apr 2026
    The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche's top-selling drug ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (PPMS) -...
  • Semaglutide improves liver function independently of weight loss
    News - 15 Apr 2026
    Researchers at Toronto's Sinai Health have found that semaglutide – the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1 – acts directly on a subset of liver cells to...
  • Adzynma
    Drug - 15 Apr 2026
    Consumer Medicine Information (CMI) about Adzynma intended for persons living in Australia.
  • Clopixol
    Drug - 14 Apr 2026
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Imbruvica
    Drug - 13 Apr 2026
    Consumer Medicine Information (CMI) about Imbruvica intended for persons living in Australia.
  • Newly developed smart molecules offer a safer and more precise approach to cancer care
    News - 7 Apr 2026
    Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback